VIC Technology Venture Development
About VIC Technology Venture Development
VIC Tech is a private technology venture development firm based in Fayetteville, Arkansas, that creates and develops high-impact life science companies. Each is built around technology exclusively licensed from top research institutions worldwide, and the firm screens roughly 1,500 technologies a year to find those with significant commercial potential.
Its model lets each startup’s technical team focus on product development while VIC’s business development team handles financing and company growth. Each new portfolio company receives a $250,000 to $500,000 seed investment from the VIC Investor Network, its affiliated angel investor network.
Portfolio companies include Akeso Biomedical, CardioWise, Cellia Science, Filtravate, IcosiMed, i-Seq Biotechnology, Neurexis Therapeutics, Nob Hill Therapeutics, SFC Fluidics, Solaris Vaccines, Vixiar, and Zebra Analytix. Recent activity includes the launch of Restara Medical, a pressure injury prevention company.
It provides startups with mentorship, management services, and access to a network of investors and industry experts.
People
- Calvin Goforth, Founder & CEO